|
Volumn 25, Issue 1, 2014, Pages 66-72
|
The effect of treatment with N-acetylcysteine on the serum levels of C-reactive protein and interleukin-6 in patients on hemodialysis.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLCYSTEINE;
ANTIINFLAMMATORY AGENT;
AUTACOID;
BIOLOGICAL MARKER;
C REACTIVE PROTEIN;
IL6 PROTEIN, HUMAN;
INTERLEUKIN 6;
ADULT;
AGED;
ARTICLE;
BLOOD;
CHRONIC KIDNEY FAILURE;
CLINICAL TRIAL;
DOWN REGULATION;
FEMALE;
HUMAN;
IMMUNOLOGY;
IRAN;
MALE;
METABOLISM;
MIDDLE AGED;
ORAL DRUG ADMINISTRATION;
RENAL REPLACEMENT THERAPY;
TIME;
TREATMENT OUTCOME;
ACETYLCYSTEINE;
ADMINISTRATION, ORAL;
ADULT;
AGED;
ANTI-INFLAMMATORY AGENTS;
BIOLOGICAL MARKERS;
C-REACTIVE PROTEIN;
DOWN-REGULATION;
FEMALE;
HUMANS;
INFLAMMATION MEDIATORS;
INTERLEUKIN-6;
IRAN;
KIDNEY FAILURE, CHRONIC;
MALE;
MIDDLE AGED;
RENAL DIALYSIS;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 84894667065
PISSN: 13192442
EISSN: None
Source Type: None
DOI: 10.4103/1319-2442.124489 Document Type: Article |
Times cited : (36)
|
References (0)
|